Market revenue in 2023 | USD 84.6 million |
Market revenue in 2030 | USD 244.2 million |
Growth rate | 16.3% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Sequencing & Data Analytics Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to metagenomics market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 61.47% in 2023. Horizon Databook has segmented the China metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
China has one of the fastest growing and most advanced metagenomics markets. In 2020, the country’s genetic testing companies raised approximately USD 3 billion in financing. NGS can improve human health by enabling early diagnosis of rare diseases, more pathogen monitoring, and improved outcomes for cancer patients.
Each year, 4 million people in the country are diagnosed with cancer, accounting for nearly 30% of cancer-related deaths globally. Thus, NGS testing is the only way to meet the unmet needs of patients by offering personalized therapies. Furthermore, NGS has proven to be a powerful tool during the COVID-19 pandemic. These factors have fueled the demand for NGS in China.
Horizon Databook provides a detailed overview of country-level data and insights on the China metagenomics market , including forecasts for subscribers. This country databook contains high-level insights into China metagenomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account